|
Volumn 15, Issue 4, 2005, Pages 739-745
|
Analysis of trichotomous pharmaceutical endpoints
|
Author keywords
Adaptive tests; Ordered categorical data; Power; Prior information
|
Indexed keywords
ANTIEMETIC AGENT;
CHLORPROMAZINE;
CISPLATIN;
DEXAMETHASONE;
FIBRINOLYTIC AGENT;
ONDANSETRON;
ADAPTIVE DESIGN;
ARTICLE;
CANCER;
CANCER CHEMOTHERAPY;
CARDIOVASCULAR DISEASE;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
DATA ANALYSIS;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
MAXIMUM LIKELIHOOD METHOD;
METHODOLOGY;
ONCOLOGY;
PRIORITY JOURNAL;
PROBABILITY;
RHEUMATIC DISEASE;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ALGORITHMS;
CLINICAL TRIALS;
CONFIDENCE INTERVALS;
DRUG THERAPY;
EMETICS;
ENDPOINT DETERMINATION;
HUMANS;
MYOCARDIAL INFARCTION;
ODDS RATIO;
RESEARCH DESIGN;
THROMBOLYTIC THERAPY;
|
EID: 22044436076
PISSN: 10543406
EISSN: None
Source Type: Journal
DOI: 10.1081/BIP-200062295 Document Type: Article |
Times cited : (3)
|
References (7)
|